1
Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)
Condition(s):Hepatitis B; PertussisLast Updated:June 9, 2020Completed
VAXELIS: 7 Clinical Trials
Hide Studies Not Open or Pending
2
A Hepatitis B Vaccine Challenge Study After Previous Vaxelis® Vaccination (V419-013)
Condition(s):Hepatitis BLast Updated:January 6, 2021Completed
3
A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)’s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV’s Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers
Condition(s):DiphtheriaLast Updated:January 18, 2021Not yet recruiting
4
Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026)
Condition(s):Pneumococcal InfectionsLast Updated:July 14, 2020Active, not recruiting
5
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)
Condition(s):Bacterial Infections; Virus DiseasesLast Updated:April 2, 2019Completed
6
Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)
Condition(s):Neisseria Meningitidis; Bacterial Infections; Virus DiseasesLast Updated:February 25, 2019Completed
7
Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)
Condition(s):Neisseria Meningitidis; Bacterial Infections; Virus DiseasesLast Updated:March 28, 2019Completed